Growth hormone and IGF-1 are related signals, but they are not the same molecule or interchangeable product names. Understanding their relationship helps explain why a change in a hormone marker is not automatically a treatment recommendation.
Separate an upstream signal from a downstream response
Growth hormone participates in signaling that influences IGF-1, while IGF-1 has its own actions and binding context. Measuring one signal is not identical to measuring the other.
Do not equate a catalog variant with every clinical product
The catalog contains IGF-1 LR3. The LR3 designation identifies a variant and should remain explicit; it cannot be silently substituted for every mention of IGF-1 in clinical literature.
Compare a defined question rather than a slogan
If the question concerns a clinical condition, the diagnosis and intended outcome determine the discussion. If it concerns a product, the exact molecule, formulation and label determine the comparison.
Is IGF-1 LR3 simply another name for HGH?
No. It identifies a different compound variant, not a somatropin presentation.
Related reading
- HGH vs Anabolic Steroids: Why Muscle Claims Need Separate Evidence
- Best HGH Brand? Compare Somatropin Products by Verifiable Details
- HGH vs Testosterone: Different Hormones, Different Questions
